Rethinking Bone Disease in Kidney Disease - Wikidata - awgldk - TriplyDB

Rethinking Bone Disease in Kidney Disease

Rethinking Bone Disease in Kidney Disease

http://www.wikidata.org/entity/Q59126536

about

Rethinking Bone Disease in Kidney Disease

http://www.wikidata.org/entity/Q59126536

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Rethinking Bone Disease in Kidney Disease

@en

Rethinking Bone Disease in Kidney Disease

@nl

type

label

Rethinking Bone Disease in Kidney Disease

@en

Rethinking Bone Disease in Kidney Disease

@nl

prefLabel

Rethinking Bone Disease in Kidney Disease

@en

Rethinking Bone Disease in Kidney Disease

@nl

P1433

Q59126536-5A3AADB2-9205-481E-9D30-87EF104ED9E2

P1476

Q59126536-9349B9ED-B8AE-4379-B14D-1ED03EE06C2F

P2093

Q59126536-532D9C1C-627D-44D6-B86B-0A2E895122B8

Q59126536-C7397723-351B-403A-A9D1-ED0913E5A2CA

P2860

Q59126536-020509C2-9C6F-4067-B42E-580B526E0F77

Q59126536-096D115A-F6A9-47C7-957F-9263A7509797

Q59126536-0A2B1CED-2DB4-4B14-9147-182377A317E2

Q59126536-0B0FBFA7-6A64-4536-84FB-FA98CC05D419

Q59126536-0B9C2D05-8433-4065-ACC9-1C31908B82EA

Q59126536-0BBC8195-1986-44FD-AEFD-C07F28EB7163

Q59126536-0D949069-AD78-4F84-AA0B-0FB43C9EDEB5

Q59126536-153BA77B-D6CF-4BF7-AF21-B490763336F8

Q59126536-19845F2E-6FF3-48DC-A3CE-B4B0E0C01013

Q59126536-1DF183A7-A754-4A41-9324-650A1782168E

P304

Q59126536-EB541067-6843-4748-91AE-446CB9F1B4BA

P31

Q59126536-32921A77-CE72-4452-A72F-4BFB854D6BC8

P356

Q59126536-CA3BC660-2EFB-4938-9B47-7C348425F5C1

P407

Q59126536-95951DBD-2BAA-421E-A3DD-FB95F5F3EB4D

P433

Q59126536-D0F23D2F-EAD1-4AB2-9441-E1FA35808F38

P478

Q59126536-AFEA9760-B2FF-4BC7-BD2F-B6E36D747014

P577

Q59126536-44E8D7F6-85A4-414B-BB9F-C52790CF7B88

P698

Q59126536-6EFDE755-60AD-414E-BB9D-A8EC5FBD6EF4

P932

Q59126536-D7ADB1A4-EEDF-400A-B68D-3046E9DC4B78

P356

P1433

P1476

Rethinking Bone Disease in Kidney Disease

@en

P2093

Matthew J Damasiewicz

http://www.w3.org/2001/XMLSchema#string

Thomas L Nickolas

http://www.w3.org/2001/XMLSchema#string

P2860

Functional and structural diversity of the human Dickkopf gene family

Phosphate and FGF-23

FRAX and the assessment of fracture probability in men and women from the UK

Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

P304

309-322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBM4.10117

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30460334

http://www.w3.org/2001/XMLSchema#string

P932

6237213

http://www.w3.org/2001/XMLSchema#string